Which biopsy is best for detecting a rare bile duct cancer?

NCT ID NCT05993429

First seen Jan 27, 2026 · Last updated Apr 30, 2026 · Updated 13 times

Summary

This study looked at 200 adults with suspected hilar cholangiocarcinoma, a rare bile duct cancer. It compared two ways to take tissue samples: one using an endoscope through the mouth (EUS-FNA/B) and another using a scope to reach the bile duct (ERCP with or without a special camera). The goal was to see which method is more accurate and safer for diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Qilu Hospital of Shandong University

    Jinan, Shandong, 250063, China

Conditions

Explore the condition pages connected to this study.